Table 3.
Mechanisms | |
(1) By inhibiting the adhesion of pathogens to the epithelium in a nonspecific manner or by competing for specific receptors and nutrients | |
(2) By producing antimicrobial agents against pathogens | |
(3) By inducing mucin production in the epithelial cells | |
(4) By strengthening the mucosal barrier through the regeneration of epithelial cells and reduction of permeability | |
(5) By modulating the immune system through the antigen-presenting cells | |
(6) By inducing cytokine production from the epithelial and immune cells, resulting in enhanced cell-mediated immune responses and the activation of cytotoxic T cells, phagocytic cells, and NK cells | |
(7) By increasing the proliferation of B cells through the induction of cytokines, which travel to secondary lymphatic organs in mucosa-associated lymphoid tissue and differentiate into immunoglobulin-producing plasma cells that may return to gut-associated lymphoid tissue by inducing the production of specific antibodies such as secretory IgA |